DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients
出版年份 2012 全文链接
标题
DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients
作者
关键词
-
出版物
Oncogenesis
Volume 1, Issue 10, Pages e30-e30
出版商
Springer Nature
发表日期
2012-10-22
DOI
10.1038/oncsis.2012.29
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An extra allele of Chk1 limits oncogene-induced replicative stress and promotes transformation
- (2012) Andres J. López-Contreras et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
- (2012) Johannes R Kratz et al. LANCET
- Plk1 and CK2 Act in Concert to Regulate Rad51 during DNA Double Strand Break Repair
- (2012) Keiko Yata et al. MOLECULAR CELL
- HERC2 Interacts with Claspin and Regulates DNA Origin Firing and Replication Fork Progression
- (2011) N. Izawa et al. CANCER RESEARCH
- Brca2, Rad51 and Mre11: Performing balancing acts on replication forks
- (2011) Vincenzo Costanzo DNA REPAIR
- Prognostic and Predictive Value of a Malignancy-Risk Gene Signature in Early-Stage Non–Small Cell Lung Cancer
- (2011) Dung-Tsa Chen et al. JNCI-Journal of the National Cancer Institute
- Plk1 Phosphorylation of Orc2 Promotes DNA Replication under Conditions of Stress
- (2011) B. Song et al. MOLECULAR AND CELLULAR BIOLOGY
- Targeting ATR and Chk1 kinases for cancer treatment: A new model for new (and old) drugs
- (2011) Luis I. Toledo et al. Molecular Oncology
- 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
- (2010) Samuel F. Bunting et al. CELL
- MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer
- (2010) et al. CLINICAL CANCER RESEARCH
- Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer
- (2010) Chang-Qi Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Expression-Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use?
- (2010) J. Subramanian et al. JNCI-Journal of the National Cancer Institute
- Increased origin activity in transformed versus normal cells: identification of novel protein players involved in DNA replication and cellular transformation
- (2010) Domenic Di Paola et al. NUCLEIC ACIDS RESEARCH
- DNA polymerase up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability
- (2010) F. Lemee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human DNA Polymerase Is Required for Common Fragile Site Stability during Unperturbed DNA Replication
- (2009) L. Rey et al. MOLECULAR AND CELLULAR BIOLOGY
- A ‘DNA replication’ signature of progression and negative outcome in colorectal cancer
- (2009) M-J Pillaire et al. ONCOGENE
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
- (2008) Kerby Shedden et al. NATURE MEDICINE
- Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication
- (2008) Arkaitz Ibarra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interaction between HMGA1a and the origin recognition complex creates site-specific replication origins
- (2008) A. W. Thomae et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Oncogene-Induced DNA Damage Model for Cancer Development
- (2008) T. D. Halazonetis et al. SCIENCE
- DNA polymerase θ (POLQ) can extend from mismatches and from bases opposite a (6-4) photoproduct
- (2007) Mineaki Seki et al. DNA REPAIR
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started